The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve ...
The ALS therapy candidate AP-101 significantly extended patient survival and delayed the need for respiratory support in a ...
One ALS patient received TRE-515 under the FDA program last year, and early signs suggest the therapy may help stabilize ...
Every few months for the past three years, Jeff Vierstra has been receiving infusions in his spine that target and disable a ...
ALS is life‑changing, but new treatments, specialized care, and innovative research are bringing real hope. See how advances at University of Utah Health are shaping the future of ALS care.
The search for an ALS cure, which has remained a mystery to the health care community, is now being sought out with the help ...
The study is a promising breakthrough that could eventually prove key to understanding the disease’s mysterious origins, its ...
According to the CDC, around 5,000 people in the U.S. are diagnosed with ALS every year. There is no cure for this neurological illness. Although anglers across the Northland were taking advantage of ...
Trace Neuroscience, a member of BioSpace’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims ...
It's a terminal disease, currently with no cure. ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully ...
An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...
Augie’s Quest to Cure ALS hosted its inaugural charity golf tournament on March 16 at Fairbanks Ranch Country Club. The event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results